Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MACITENTAN\TADALAFIL Cause Product dose omission issue? 46 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Product dose omission issue have been filed in association with MACITENTAN\TADALAFIL. This represents 8.4% of all adverse event reports for MACITENTAN\TADALAFIL.

46
Reports of Product dose omission issue with MACITENTAN\TADALAFIL
8.4%
of all MACITENTAN\TADALAFIL reports
0
Deaths
3
Hospitalizations

How Dangerous Is Product dose omission issue From MACITENTAN\TADALAFIL?

Of the 46 reports, 3 (6.5%) required hospitalization.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MACITENTAN\TADALAFIL. However, 46 reports have been filed with the FAERS database.

What Other Side Effects Does MACITENTAN\TADALAFIL Cause?

Headache (75) Dyspnoea (56) Hospitalisation (42) Dizziness (32) Death (30) Diarrhoea (29) Fatigue (25) Adverse drug reaction (24) Hypotension (22) Nausea (21)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which MACITENTAN\TADALAFIL Alternatives Have Lower Product dose omission issue Risk?

MACITENTAN\TADALAFIL vs MAGNESIUM MACITENTAN\TADALAFIL vs MAGNESIUM ASPARTATE MACITENTAN\TADALAFIL vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE MACITENTAN\TADALAFIL vs MAGNESIUM HYDROXIDE MACITENTAN\TADALAFIL vs MAGNESIUM OROTATE

Related Pages

MACITENTAN\TADALAFIL Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue MACITENTAN\TADALAFIL Demographics